Investor Relations

Company Description

News

Financial Reports

Financial Calendar

Presentations

The Share

New Issues

Corporate Governance

IR Contact

Dignitana signs master contract with Hartford HealthCare

Files for download
Dignitana Release - wkr0006.pdf

Dignitana AB, world leader in scalp cooling innovation, announced today that the Company has signed a master contract with Hartford HealthCare in the U.S. to provide DigniCap Delta® at up to seven locations in Connecticut. The FDA-cleared DigniCap® Scalp Cooling System minimizes hair loss from chemotherapy in patients with solid tumors.

St. Vincent's Medical Center in Bridgeport, Connecticut will be the first location in the group to implement DigniCap later this month.

“Hartford HealthCare is a recognized leader in clinical excellence and healthcare innovation,” said William Cronin, Chief Executive Officer of Dignitana AB.  “We are honored to welcome them to the growing list of providers selecting DigniCap so patients can maintain privacy, identity and control during cancer treatment.”

Hartford HealthCare is a large regional healthcare system with seven hospitals and more than 350 locations in Connecticut and Rhode Island. With a strong, unified culture of accountability and innovation, The Hartford HealthCare Cancer Institute offers a single, high standard of care treating over 6,000 new cancer cases each year.

The DigniCap Scalp Cooling System is available at over 160 locations in 30 states in the U.S. and in 38 markets globally.

For More Information Contact

Investor Relations +1 469 518 5031 investorrelations@dignitana.com

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com. Eric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 certifiedadviser@penser.se www.penser.se